NR4A1 and breast cancer: Similarly, Fortner et al. conducted a case-control study nested in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort to investigate the association between circulating OPG levels and breast cancer risk by hormone receptor type and matched breast cancer cases with healthy controls [40].